[Indications and contraindications for therapy with cardiac glycosides].
Today glycosides have 3 indications: manifest and chronic cardiac insufficiency, arrhythmia absoluta and paroxysmal supraventricular tachycardia. Glycosides are no longer important in the therapy of acute cardiac insufficiency. There are also absolute and relative contraindications which should be recognized; in coronary heart disease glycosides should only be used if there is really a latent of manifest cardiac insufficiency.
D000200:Action Potentials / Q000187:drug effects; D001283:Atrioventricular Node / Q000187:drug effects; D002301:Cardiac Glycosides / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000139:chemically induced
D002301:Cardiac Glycosides; D014665:Vasodilator Agents
Indikationen und Kontraindikationen für eine Therapie mit Herzglykosiden.